diflunisal 375 MG Oral Tablet [Dolobid]
diflunisal
RxCUI: 2691103
What the CMS Formulary Data Shows for diflunisal 375 MG Oral Tablet [Dolobid]
Per the CMS 2026 Part D formulary file, diflunisal 375 MG Oral Tablet [Dolobid] (RxNorm concept RXCUI 2691103, generic name diflunisal) appears on 2 distinct formulary files spanning 115 Medicare Part D plan offerings - 2.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 5 to Tier 5, with a cross-plan average of Tier 5.
Real-world access to diflunisal 375 MG Oral Tablet [Dolobid] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,325 Part D beneficiaries filled diflunisal 375 MG Oral Tablet [Dolobid] in 2023, with total plan-and-beneficiary spending of $859,181 and an average per-beneficiary annual cost of $258.40. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry diflunisal 375 MG Oral Tablet [Dolobid] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 115
- Coverage rate
- 2.3%
- Tier range
- Tier 5, Specialty
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,325
- Total spending
- $859,181
- Avg per beneficiary
- $258.40
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering diflunisal 375 MG Oral Tablet [Dolobid]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is diflunisal 375 MG Oral Tablet [Dolobid] covered by Medicare Part D?
Yes, diflunisal 375 MG Oral Tablet [Dolobid] is covered by 115 Medicare Part D plans (2.3% of all Part D formularies).
What tier is diflunisal 375 MG Oral Tablet [Dolobid] on Medicare Part D plans?
diflunisal 375 MG Oral Tablet [Dolobid] averages Tier 5 across Part D plans, ranging from Tier 5 to Tier 5.
Does diflunisal 375 MG Oral Tablet [Dolobid] require prior authorization?
0% of Part D formularies require prior authorization for diflunisal 375 MG Oral Tablet [Dolobid]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on diflunisal 375 MG Oral Tablet [Dolobid]?
In 2023, total Medicare Part D spending on diflunisal 375 MG Oral Tablet [Dolobid] was $859,181, covering 3,325 beneficiaries. The average spend per beneficiary was $258.40.
Read our methodology - how this data is sourced, computed, and verified.